Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Augusto Valdivia"'
Publikováno v:
Barcelona Respiratory Network Reviews, Vol 10, Iss 1 (2024)
Non-small-cell lung cancer (NSCLC) is the most frequent type of lung cancer, currently a leading cause of cancer-related death worldwide. The development of molecular biomarkers has led to novel treatment strategies and subsequent improvement in surv
Externí odkaz:
https://doaj.org/article/d600cb5f789a42a399489af6661de192
Autor:
Caterina Carbonell, Joan Frigola, Nuria Pardo, Ana Callejo, Patricia Iranzo, Augusto Valdivia, Ilaria Priano, Susana Cedrés, Alex Martinez‐Marti, Alejandro Navarro, Laura Lenza, Mireia Soleda, Javier Gonzalo‐Ruiz, Ana Vivancos, Miriam Sansó, Enric Carcereny, Teresa Morán, Ramon Amat, Enriqueta Felip
Publikováno v:
Molecular Oncology, Vol 17, Iss 5, Pp 779-791 (2023)
Immune checkpoint inhibitors (ICIs) targeting the PD‐1/PD‐L1 axis are the main therapeutic option for patients with advanced non‐small cell lung cancer (NSCLC) without a druggable oncogenic alteration. Nevertheless, only a portion of patients b
Externí odkaz:
https://doaj.org/article/604e6cdc2d234a06b5347b1a01ff2632
Autor:
Cristina Suarez, David Marmolejo, Augusto Valdivia, Rafael Morales-Barrera, Macarena Gonzalez, Joaquin Mateo, Maria Eugenia Semidey, David Lorente, Enrique Trilla, Joan Carles
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Collecting duct renal cell carcinoma (cdRCC), which until recently was thought to arise from the collecting ducts of Bellini in the renal medulla, is a rare and aggressive type of non-clear renal cell carcinoma (ncRCC), accounting for 1% of all renal
Externí odkaz:
https://doaj.org/article/76d867817a8c43dba11b886e3239f14f
Publikováno v:
Medical Sciences, Vol 11, Iss 3, p 46 (2023)
Von Hippel–Lindau (VHL) loss is the hallmark event characterizing the clear cell renal cancer subtype (ccRCC). Carriers of germinal VHL mutations have an increased prevalence of kidney cysts and ccRCC as well as hemangioblastoma, pheochromocytoma a
Externí odkaz:
https://doaj.org/article/dfd2fa49f1b64541a92d5ea8c4141904
Autor:
Caterina Carbonell, Joan Frigola, Nuria Pardo, Ana Callejo, Patricia Iranzo, Augusto Valdivia, Ilaria Priano, Susana Cedrés, Alex Martinez‐Marti, Alejandro Navarro, Laura Lenza, Mireia Soleda, Javier Gonzalo‐Ruiz, Ana Vivancos, Miriam Sansó, Enric Carcereny, Teresa Morán, Ramon Amat, Enriqueta Felip
Publikováno v:
Scientia
Immune checkpoint inhibitors; Liquid biopsy Inhibidores del punto de control inmunitario; Biopsia líquida Inhibidors del punt de control immunitari; Biòpsia líquida Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis are the main the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4156dbba9cbf2c8c3049073dd52fe1ee
https://doi.org/10.1002/1878-0261.13409
https://doi.org/10.1002/1878-0261.13409
Autor:
Samuel Rosner, Augusto Valdivia, Hui Jing Hoe, Joseph C. Murray, Benjamin Levy, Enriqueta Felip, Benjamin J. Solomon
Publikováno v:
American Society of Clinical Oncology Educational Book.
Antibody Drug Conjugates (ADCs) are a novel class of therapeutic that structurally comprise an antibody directed at a tumor epitope connected via a linker to a cytotoxic payload that have shown significant antitumor activity across a range of maligna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::780510b0405ce5aeff067e3995657d47
https://doi.org/10.1200/edbk_389968
https://doi.org/10.1200/edbk_389968
Autor:
null Caterina Carbonell, null Joan Frigola, null Nuria Pardo, null Ana Callejo, null Patricia Iranzo, null Augusto Valdivia, null Ilaria Priano, null Susana Cedrés, null Alex Martinez‐Marti, null Alejandro Navarro, null Laura Lenza, null Mireia Soleda, null Javier Gonzalo‐Ruiz, null Ana Vivancos, null Miriam Sansó, null Enric Carcereny, null Teresa Morán, null Ramon Amat, null Enriqueta Felip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53fb5ec0ecd09e6431a3b5b7a48b0577
https://doi.org/10.1002/1878-0261.13409/v2/response1
https://doi.org/10.1002/1878-0261.13409/v2/response1
Autor:
David Illescas, Carmen García-Durán, Víctor Navarro, Augusto Valdivia, Lorena Fariñas Madrid, Guillermo Villacampa, Ana Oaknin, Juan Francisco Grau, null Vall d’Hebron University Hospital, Barcelona, Spain
Publikováno v:
Gynecologic Oncology. 166:S240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f74b1074068ecce430dbfa6ab5eaded
https://doi.org/10.1016/s0090-8258(22)01706-1
https://doi.org/10.1016/s0090-8258(22)01706-1
Publikováno v:
Journal of Cancer Metastasis and Treatment. 8:35
Cervical cancer is the fourth most common cancer in women worldwide, with a global incidence of 604,127 and an annual death rate of 341,831 in 2020. Patients with recurrent, persistent, or metastatic disease not amenable to curative therapy represent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd201aa60bc308baa63c6f5b96cbc12c
https://doi.org/10.20517/2394-4722.2022.34
https://doi.org/10.20517/2394-4722.2022.34
Publikováno v:
American Journal of Gastroenterology. 110:S495-S496
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76818e7070b44f14dc3c34438861d1ce
https://doi.org/10.14309/00000434-201510001-01137
https://doi.org/10.14309/00000434-201510001-01137